Abstract:BACKGROUND: The lack of new anthelmintic agents is of growing concern because it affects human health and our food supply, as both livestock and plants are affected. Two principal factors contribute to this problem. First, nematode resistance to anthelmintic drugs is increasing worldwide and second, many effective nematicides pose environmental hazards. In this paper we address this problem by deploying a high throughput screening platform for anthelmintic drug discovery using the nematode Caenorhabditis elegans as a surrogate for infectious nematodes. This method offers the possibility of identifying new anthelmintics in a cost-effective and timely manner.METHODS/PRINCIPAL FINDINGS: Using our high throughput screening platform we have identified 14 new potential anthelmintics by screening more than 26,000 compounds from the Chembridge and Maybridge chemical libraries. Using phylogenetic profiling we identified a subset of the 14 compounds as potential anthelmintics based on the relative sensitivity of C. elegans when compared to yeast and mammalian cells in culture. We showed that a subset of these compounds might employ mechanisms distinct from currently used anthelmintics by testing diverse drug resistant strains of C. elegans. One of these newly identified compounds targets mitochondrial complex II, and we used structural analysis of the target to suggest how differential binding of this compound may account for its different effects in nematodes versus mammalian cells.CONCLUSIONS/SIGNIFICANCE: The challenge of anthelmintic drug discovery is exacerbated by several factors; including, 1) the biochemical similarity between host and parasite genomes, 2) the geographic location of parasitic nematodes and 3) the rapid development of resistance. Accordingly, an approach that can screen large compound collections rapidly is required. C. elegans as a surrogate parasite offers the ability to screen compounds rapidly and, equally importantly, with specificity, thus reducing the potential toxicity of these compounds to the host and the environment. We believe this approach will help to replenish the pipeline of potential nematicides.

[Mediastinal bronchogenic cyst associated with a multiple malformation syndrome].

Biophysical phenotyping of C. elegans in a microfluidic chip for high-throughput drug screening

Identification of Small-Molecule Ion Channel Modulators in C. Elegans Channelopathy Models.

Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B2 receptor antagonist peptide Hoe 140.

Advances in C. elegans behavior research with microfluidic devices and its future prospects in the evaluation of exogenous pollutants

An automated microfluidic platform for toxicity testing based on Caenorhabditis elegans

Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity

A high-throughput microplate toxicity screening platform based on Caenorhabditis elegans

On-demand Dielectrophoretic Immobilization and High-Resolution Imaging of C. Elegans in Microfluids

Flexible and disposable paper- and plastic-based gel micropads for nematode handling, imaging, and chemical testing

Pluronic gel-based burrowing assay for rapid assessment of neuromuscular health in C. elegans

Abductive Change Operators

[A case of posttraumatic thrombosis of the basilar trunk with anatomic examination].

A Microfluidic Platform for Longitudinal Imaging in Caenorhabditis elegans

Scalable Electrophysiology of Millimeter-Scale Animals with Electrode Devices

A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans

A novel assay for drug screening that utilizes the heat shock response of Caenorhabditis elegans nematodes

An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs

In vivo quantitative high-throughput screening for drug discovery and comparative toxicology

Deep wound dehiscence of clamshell incision, successful management

Use of Viscous medium to study anthelmintic drug action in Caenorhabditis elegans